Cassava Sciences Stock Plummets Amid Trial Failure and Shkreli’s Takedown
Cassava Sciences, Inc. (NASDAQ: SAVA) witnessed a dramatic over 85% plunge in its stock price following the release of disappointing
Read more
Cassava Sciences
Cassava Sciences Replaces Entire Management Team Amid Data Falsification Scandal
Cassava Sciences (NASDAQ: SAVA) announced a sweeping overhaul of its leadership following revelations of data falsification in its Alzheimer’s drug
Read more
Cassava Sciences Answers Allegations Of Fraud: “We’re Not An Entertainment Company; We’re A Science Shop”
Cassava Sciences, Inc. (Nasdaq: SAVA) saught this morning to put an end to the allegations of fraud being made towards
Read more